Clinical trials
Completed Hidradenitis Suppurativa trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 5 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UCB Biopharma SRL | 4 |
| Boehringer Ingelheim | 3 |
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Avalo Therapeutics, Inc. | 1 |
| Azora Therapeutics Australia Pty Ltd | 1 |
| CSL Behring | 1 |
| Holdsworth House Medical Practice | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hidradenitis Suppurativa | 19 |
| Hidradenitis | 1 |
| Psoriasis | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.